Input
What you provide
- Asset, target, or indication
- Trials, papers, patents, regulatory records, or decks
- Team notes or diligence questions
- Next-step criteria for the program
App Data / Drug Development
Drug Program Diligence
Turn one drug program into a clean diligence file.
Send an asset, target, indication, sources, notes, and diligence questions. The app organizes claims, sources, gaps, risks, and next-step notes into one file. Ready to scope now. Start with one real batch and get back the output your team can use.
Available nowAvailable now. Start with one asset or program.
Input, work, and output
Work
What happens
- Links program claims to the sources you provide or connect
- Names missing sources, gaps, and unresolved risks
- Organizes trial, literature, patent, and regulatory context
- Prepares a diligence file for portfolio or BD work
Output
What you receive
- Asset diligence file
- Source list and citation trail
- Risks, gaps, and next-step notes
- Program handoff for diligence or portfolio work
Decision flow
Move from intake to review and handoff with clear owners at every step.
01
Load the program
Start from the asset, target, indication, or source set.
Claims stay attached to source records.
02
Organize sources
Trials, literature, patents, and regulatory records are grouped around the program questions.
Missing sources are named.
03
Prepare the diligence file
The output is one file the portfolio or BD team can read.
Claims and sources travel together.
04
Keep program memory
Rejected hypotheses and accepted source links remain available for the next pass.
Repeat work is reduced.
What you receive
Drug Program Diligence deliverables
- Application
- Drug Program DiligenceAvailable now
- Buyer
- Biotech, pharma BD, portfolio, and diligence teamsProgram owner
- Input
- asset or source setassets / trials / papers / patents / decks
- Review
- Program ownerLinks program claims to the sources you provide or connect Names missing sources, gaps, and unresolved risks Organizes trial, literature, patent, and regulatory context Prepares a diligence file for portfolio or BD work
- Output
- Asset file with claims, sources, trial and regulatory context, risks, and next-step notes.Checked asset sources, source trail, and diligence files your drug-development team can keep.
- Scope
- $75K-$300K typical engagementTypical engagement
What the workflow supports
| Outcome | Work | What you receive | Program fit |
|---|---|---|---|
| Input is ready | Asset, target, or indication Trials, papers, patents, regulatory records, or decks Team notes or diligence questions Next-step criteria for the program | Source, access, format, validation, project rules, and responsible owner. | Best for teams with a defined source, owner, and delivery goal. |
| Work can advance | Links program claims to the sources you provide or connect Names missing sources, gaps, and unresolved risks Organizes trial, literature, patent, and regulatory context Prepares a diligence file for portfolio or BD work | Stage, owner, checks, exceptions, reviewer notes, and required next action. | Your team can see blockers, owners, and next actions throughout the workflow. |
| Output can be released | Asset diligence file Source list and citation trail Risks, gaps, and next-step notes Program handoff for diligence or portfolio work | Sources, criteria, reviewers, decision, manifest, version, and audit history. | The final package is configured for the application, project, and review requirements. |
Good fit
What this application is for
- BD diligence
- Portfolio meetings
- Clinical strategy prep
- Asset source cleanup
Works alongside
What stays with your team
- Medical advice
- Replacing scientific, clinical, legal, or regulatory judgment
Availability
Available nowAvailable now as a scoped program diligence app with source access defined up front.